SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the community discusses the potential impact of a failed Alzheimer's drug trial on its stock, despite its dominance in the obesity market with drugs like Wegovy, where community members speculate on the possibility of a price war. Some investors view the dip as a buying opportunity, emphasizing the company's strong fundamentals and long-term potential in the weight loss sector, while others worry about competition from other pharmaceutical companies. There is also discussion around potential acquisitions and partnerships.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending due to reports of a potential extension of Obamacare subsidies, sparking both bullish and bearish sentiments within the community. Bulls anticipate significant gains if the subsidies are extended, while bears express concerns about the company's long-term viability and potential challenges in improving medical loss ratios. Community members are actively discussing potential price targets, entry points, and the overall impact of policy changes on the healthcare sector.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending as discussions swirl around the company potentially allowing Bitcoin and Ethereum as loan collateral, a move seen by some as a major shift despite CEO Jamie Dimon's past skepticism towards crypto. The community is also buzzing about a possible silent war between JPMorgan and MicroStrategy ($MSTR), with some calling for a boycott of the bank. Technical analysis suggests JPM's chart indicates a possible support bounce or breakdown.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

GOOG is trending as community members discuss the potential impact of its new Gemini 3 model, with some suggesting it could be a game-changer in the AI race and drive further gains. Bullish sentiment is fueled by positive analyst ratings and Waymo's expansion, while some traders are closely watching for a potential pullback after the recent surge.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide ($WRD) is trending due to robotaxi revenue growth and global expansion milestones, including approvals for driverless operations in Abu Dhabi and partnerships with Uber and Grab. The community is buzzing about the company's potential to monetize AI and compete with Tesla in the robotaxi market. Discussions also highlight WeRide's strategic partnerships and the rapid development of China's autonomous driving technology.

Monad

Monad is trending as its public mainnet launch and token listing approaches, sparking excitement and debate within the crypto community. Discussions revolve around the token distribution process, potential for profit, and where to purchase, alongside speculation about a possible initial price surge and subsequent dip. Some users express concerns about it being a potential scam, while others highlight its listing on Coinbase as a positive sign.

Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Molina Healthcare Inc

MOH is trending as the community discusses its recent rating adjustments from various firms and a significant price drop following disappointing earnings, which missed estimates due to rising medical costs. Community members are weighing the potential for a rebound, citing the company's balance sheet, while others express concerns about sector-wide challenges and potential downgrades. Discussions also revolve around the impact of Medicaid and Medicare policies on the company's revenue streams.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as its Qwen AI app reached 10 million downloads, driving optimism despite broader market AI skepticism. Community members are actively discussing the app's potential to rival ChatGPT and the implications for Alibaba's AI strategy. The news has sparked debate about the stock's valuation and future prospects within the competitive tech landscape.

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

MSI is trending due to community focus on technical analysis, particularly positive divergence and significant dark pool activity suggesting a potential oversold bounce. Traders are pointing to a large dark pool print as a sign of a bottom and reversal. The stock's oversold condition and potential for a bounce are key talking points.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi ($SNY) is trending amid speculation and rumors surrounding potential acquisitions in the biotech space, particularly within the MASH and obesity sectors. Community discussions highlight $SNY as a possible suitor for companies like $ALT, $GUTS, and $IVA, with some suggesting a bidding war could emerge; however, there are counterarguments about data integrity and trial concerns with certain targets. Conversations also touch upon $SNY's pipeline expansion strategies and its financial capacity for acquisitions, while some criticize the company's labor practices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aquestive Therapeutics (NASDAQ:AQST) Trading Up 6.5% - Here's Why

Aquestive Therapeutics (NASDAQ:AQST) Stock Price Up 6.5% - Here's What Happened...

Leerink Partnrs Has Pessimistic View of AQST Q4 Earnings

Aquestive Therapeutics, Inc. (NASDAQ:AQST - Free Report) - Research analysts at Leerink Partnrs dropped their Q4 2025 EPS estimates for shares of Aquestive Therapeutics in a research report issued on...

HC Wainwright Has Pessimistic View of AQST FY2025 Earnings

Aquestive Therapeutics, Inc. (NASDAQ:AQST - Free Report) - Equities research analysts at HC Wainwright decreased their FY2025 EPS estimates for shares of Aquestive Therapeutics in a research note...

Lightning Round: Joby Aviation is losing too much money, says Jim Cramer

'Mad Money' host Jim Cramer weighs in on stocks including: Applovin, Aquestive Therapeutics, and Joby Aviation...

Aquestive Therapeutics (NASDAQ:AQST) Stock Price Down 5.9% - Here's What Happened

Aquestive Therapeutics (NASDAQ:AQST) Stock Price Down 5.9% - Here's What Happened...

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Average Rating of "Buy" from Brokerages

Aquestive Therapeutics, Inc. (NASDAQ:AQST - Get Free Report) has received an average rating of "Buy" from the eleven analysts that are currently covering the stock, MarketBeat.com reports. One...

Aquestive Therapeutics (NASDAQ:AQST) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen raised Aquestive Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Aquestive Therapeutics (NASDAQ:AQST) Releases Earnings Results

Aquestive Therapeutics (NASDAQ:AQST - Get Free Report) released its earnings results on Wednesday. The company reported ($0.14) earnings per share for the quarter, missing analysts' consensus...

Here's What Key Metrics Tell Us About Aquestive Therapeutics (AQST) Q3 Earnings

Although the revenue and EPS for Aquestive Therapeutics (AQST) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aquestive Therapeutics (AQST) Reports Q3 Loss, Lags Revenue Estimates

Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -7.69% and -4.13%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Current Price	$5.72
Prev Close	$5.62
Open	$5.54
Dividend Yield	0.00%
50-Day Moving Average	$6.07
Beta	1.32
Avg. Volume	2.98M
PE Ratio	-8.13

52-Week High	$7.55
52-Week Low	$2.12
Market Capitalization	$697.86M
EPS (Annual)	-$0.5089
Price to Book	-169.38
Revenue Per Employee	$405,359.16
Enterprise Value/EBITDA	N/A

AQST
Aquestive Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AQST News

AQSTAquestive Therapeutics Inc